Search results

Page results

• Biatain® dressings for radiotherapy and proton beam therapy skin reactions

  Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.

• SUMMIT Study catches up with pre-pandemic follow up appointments

  As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• Publications and Reading Material

  The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements. 

• First UK patient with multiple sclerosis trialling CAR T cell therapy at UCLH

  A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.

• Women’s mental agility is better during menstruation

  Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).

• Share your views on the future of maternity, neonatal and children’s surgical services in North London

  Everyone is invited to share their views on the future of maternity, neonatal and children’s surgical services in North Central London as a 14-week public consultation launches today.

• Hope for patients with beta thalassaemia as new gene editing therapy rolled out at UCLH

  A UCLH patient with beta thalassaemia has spent her first ever Christmas without needing to plan her life around blood transfusions after a gene-editing therapy has left her able to produce her own red blood cells.

• Getting Ready for Transition (GReaT) to secondary school

  Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 28 January 2026.

• Consenting to treatment

  Information on how we ask for your consent to treatment, and Martha's Rule.